{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T08:55:23Z","timestamp":1760345723278,"version":"3.30.2"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1990,7,1]],"date-time":"1990-07-01T00:00:00Z","timestamp":646790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":9285,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[1990,7]]},"DOI":"10.1111\/1523-1747.ep12873300","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T05:45:17Z","timestamp":1089870317000},"page":"50-54","source":"Crossref","is-referenced-by-count":41,"title":["Pharmacologic and Clinical Effects of Lonapalene (RS 43179), a 5-Lipoxygenase Inhibitor, in Psoriasis"],"prefix":"10.1016","volume":"95","author":[{"given":"Anne Kobza","family":"Black","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D R","family":"Camp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F F","family":"Derm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony I","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona M","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mechtild","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm W","family":"Greaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/1523-1747.ep12873300_bb0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/jid.1989.35","article-title":"Cutaneous pharmacology: perspectives on the growth of investigation of mediators of inflammation","volume":"92","author":"Camp","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12873300_bb0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/286264a0","article-title":"Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leucocytes","volume":"286","author":"Ford-Hutchinson","year":"1980","journal-title":"Nature"},{"key":"10.1111\/1523-1747.ep12873300_bb0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0090-6980(80)80058-X","article-title":"Chemokinetic activity of arachidonic acid lipoxygenase products on leucocytes of different species","volume":"20","author":"Palmer","year":"1980","journal-title":"Prostaglandins"},{"key":"10.1111\/1523-1747.ep12873300_bb0025","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0140-6736(82)90939-4","article-title":"Psoriasis and leukotriene B4","volume":"2","author":"Brain","year":"1982","journal-title":"Lancet"},{"key":"10.1111\/1523-1747.ep12873300_bb0030","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/1523-1747.ep12261712","article-title":"The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis","volume":"83","author":"Brain","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12873300_bb0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1476-5381.1984.tb10148.x","article-title":"Leukotriene B4-like material in scale of psoriatic lesions","volume":"83","author":"Brain","year":"1984","journal-title":"Br J Pharmacol"},{"key":"10.1111\/1523-1747.ep12873300_bb0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/1523-1747.ep12284061","article-title":"Skin levels of arachidonic acid derived inflammatory mediators and histamine in atopic dermatitis and psoriasis","volume":"86","author":"Ruzicka","year":"1986","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12873300_bb0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/1523-1747.ep12259945","article-title":"Production of intraepidermal microabscesses by topical application of leukotriene B4","volume":"82","author":"Camp","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12873300_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2133.1984.tb04012.x","article-title":"Levels of arachidonic acid and its metabolites in the skin in human allergic and irritant contact dermatitis","volume":"111","author":"Barr","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1111\/1523-1747.ep12873300_bb0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/1523-1747.ep12265520","article-title":"The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4","volume":"84","author":"Wong","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12873300_bb0060","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1073\/pnas.72.12.5130","article-title":"Increased concentrations of non-esterified arachidonic acid, 12 L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandins E2 and prostaglandin F2 in epidermis of psoriasis","volume":"72","author":"Hammarstrom","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/1523-1747.ep12873300_bb0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0090-6980(83)90178-8","article-title":"The identification of hydroxy fatty acids in psoriatic skin","volume":"26","author":"Camp","year":"1983","journal-title":"Prostaglandins"},{"key":"10.1111\/1523-1747.ep12873300_bb0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-291X(86)90891-0","article-title":"Stereochemical difference between 12-hydroxy5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesions","volume":"136","author":"Woollard","year":"1986","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/1523-1747.ep12873300_bb0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0378-4347(84)80018-3","article-title":"Rapid isocratic high performance liquid Chromatograpihc purification of platelet activating factor (PAF) and lyso-PAF in human skin","volume":"309","author":"Mallet","year":"1984","journal-title":"J Chromatogr"},{"key":"10.1111\/1523-1747.ep12873300_bb0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0006-291X(85)90590-X","article-title":"Structural identification of platelet activating factor in psoriatic scale","volume":"126","author":"Mallet","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/1523-1747.ep12873300_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.1986.tb02773.x","article-title":"Demonstration of anaphylotoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses","volume":"114","author":"Takematsu","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1111\/1523-1747.ep12873300_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1523-1747.ep12523566","article-title":"Identification of C5a des arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales","volume":"87","author":"Schroder","year":"1986","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12873300_bb0095","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.4049\/jimmunol.137.11.3469","article-title":"Psoriatic skin lesions contain biologically active amounts of an interleukin 1-like compound","volume":"137","author":"Camp","year":"1986","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12873300_bb0100","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1476-5381.1988.tb11620.x","article-title":"Psoriatic skin lesions contain a novel lipid neutrophil chemokinetic compound which is distinct from known chemoattractant eicosanoids","volume":"94","author":"Camp","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1111\/1523-1747.ep12873300_bb0105","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.4049\/jimmunol.140.12.4294","article-title":"Neutrophil chemoattractant and IL-1 like activity in samples from psoriatic lesions. Further characterisation","volume":"140","author":"Fincham","year":"1988","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12873300_bb0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0167-5699(89)90164-3","article-title":"Novel neutrophil-stimulating peptides","volume":"10","author":"Westwick","year":"1989","journal-title":"Immunology Today"},{"key":"10.1111\/1523-1747.ep12873300_bb0115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0090-6980(85)90084-X","article-title":"Leukotrienes C4 and D4 in psoriatic skin lesions","volume":"29","author":"Brain","year":"1985","journal-title":"Prostaglandins"},{"key":"10.1111\/1523-1747.ep12873300_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2125.1988.tb03277.x","article-title":"The in vitro 5-lipoxygenase and cyclo-oxygenase inhibitor L-652,343 does not inhibit 5-lipoxygenase in vivo in human skin","volume":"25","author":"Barr","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/1523-1747.ep12873300_bb0125","first-page":"886","article-title":"Selective inhibitors of arachidonic acid (AA) 5-lipoxygenase by a novel antipsoriatic agent 6-chloro-1,4-diacetoxy-2,3-dimethoxynapthalene (RS 43179)","volume":"44","author":"Murthy","year":"1985","journal-title":"Fed Proc"},{"key":"10.1111\/1523-1747.ep12873300_bb0130","first-page":"358","article-title":"The biological activities of the novel topical antipsoriatic agent 6-chloro-l,4-diacetoxy-2,3-dimethoxynapthalene (RS 43179)","volume":"84","author":"Young","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12873300_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2340\/00015555524348","article-title":"The psoriasis bio-assay for topical corticosteroid activity","volume":"52","author":"Dumas","year":"1972","journal-title":"Acta Dermato Venereol (Stockh)"},{"key":"10.1111\/1523-1747.ep12873300_bb0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2133.1985.tb02049.x","article-title":"A dimethoxynapthalene derivative (RS 43179 gel) compared with 0.025% fluocinolone acetonide gel in the treatment of psoriasis","volume":"113","author":"Lassus","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1111\/1523-1747.ep12873300_bb0145","first-page":"483","article-title":"A clinical trial of lonapalene, fluocinolone acetonide and vehicle in psoriasis","volume":"86","author":"Jansen","year":"1986","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12873300_bb0150","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1476-5381.1980.tb07037.x","article-title":"The effects of some antirheumatic drugs on an in vitro model of human polymorphonuclear leucocyte chemokinesis","volume":"69","author":"Smith","year":"1980","journal-title":"Br J Pharmacol"},{"key":"10.1111\/1523-1747.ep12873300_bb0155","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0090-6980(85)90122-4","article-title":"Proinflammatory properties of unsaturated fatty acids and their monohydroxy metabolites","volume":"30","author":"Cunningham","year":"1985","journal-title":"Prostaglandins"},{"key":"10.1111\/1523-1747.ep12873300_bb0160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0021-9673(00)95624-3","article-title":"Use of reversed phase gel partition chromatography for the purification of chemically synthesized [5,6,8,9,11,12,14,15n]-octadeuterium and octatritium labelled arachidonic acid","volume":"166","author":"Woollard","year":"1978","journal-title":"J Chromatogr"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X9090153W?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X9090153W?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T22:02:59Z","timestamp":1734472979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X9090153W"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,7]]}},"alternative-id":["S0022202X9090153W"],"URL":"https:\/\/doi.org\/10.1111\/1523-1747.ep12873300","relation":{},"ISSN":["0022-202X"],"issn-type":[{"type":"print","value":"0022-202X"}],"subject":[],"published":{"date-parts":[[1990,7]]}}}